Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Implantable Microdevice for TNBC - Pilot Study
- Status
- WITHDRAWN
- Phase
- PHASE1
Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis
- Status
- COMPLETED
- Phase
- N/A
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
- Status
- RECRUITING
- Phase
- NA
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Status
- RECRUITING
- Phase
- PHASE3
Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2